openPR Logo
Press release

United States At-Home Drug of Abuse (DOA) Testing Market valuation $5.09 billion by 2033 - Exclusive Report by DatamIntelligence

10-13-2025 01:21 PM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

At-Home Drug of Abuse (DOA) Testing Market

At-Home Drug of Abuse (DOA) Testing Market

"At-Home Drug of Abuse (DOA) Testing Market reached US$ 2.62 Billion in 2024 and is expected to reach US$ 5.09 Billion by 2033, growing at a CAGR of 7.7% during the forecast period 2025-2033." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/at-home-drug-of-abuse-testing-market?sp

United States: Recent Industry Developments

✅ In September 2025, Abbott launched a next-generation at-home DOA testing kit with enhanced sensitivity and easy smartphone integration for instant results. The product improves user convenience and early detection.

✅ In August 2025, OraSure Technologies expanded its at-home DOA testing portfolio with multi-panel kits covering prescription and illicit substances, supporting comprehensive monitoring.

✅ In July 2025, Labcorp introduced AI-enabled home testing solutions for substance use, providing secure reporting and personalized guidance for patients and caregivers.

✅ In June 2025, Alere invested $40 million in R&D for rapid, accurate, and non-invasive at-home drug testing devices, strengthening the U.S. point-of-care diagnostics market.

Japan: Recent Industry Developments

✅ In September 2025, Sysmex Corporation launched at-home DOA testing kits integrated with mobile apps for real-time results, enhancing accessibility and privacy for users.

✅ In August 2025, Terumo Corporation introduced multi-substance at-home testing kits with user-friendly interfaces and secure digital reporting for Japanese consumers.

✅ In July 2025, Fujifilm Wako Pure Chemical Industries developed rapid at-home drug testing solutions with enhanced sensitivity and reliability for both clinical and personal use.

✅ In June 2025, Daiichi Sankyo invested in AI-assisted at-home DOA testing platforms to improve accuracy, result interpretation, and patient support across Japan.

At-Home Drug of Abuse (DOA) Testing Market: Drivers

The at-home drug of abuse (DOA) testing market is growing rapidly due to increasing awareness of substance abuse, workplace safety concerns, and the convenience of self-testing. These tests allow individuals and caregivers to quickly screen for drugs such as opioids, cannabis, and amphetamines in the privacy of their homes. Advances in test accuracy, ease of use, and rapid result delivery are enhancing consumer confidence and adoption. Rising prevalence of substance use disorders and supportive healthcare initiatives are driving demand for accessible, reliable testing solutions. Integration with telehealth and mobile health platforms is further expanding usage and follow-up care.

Technological innovations in immunoassay kits, digital readouts, and multi-drug detection panels are improving performance and usability. Growing acceptance of home diagnostics and preventive healthcare is encouraging wider adoption across individuals, clinics, and rehabilitation centers. Expansion of retail and e-commerce channels is increasing accessibility and convenience for end-users. Government programs and awareness campaigns focused on substance abuse prevention are supporting market growth. With rising substance abuse awareness, technological advancement, and demand for convenience, the at-home drug of abuse testing market is poised for sustained growth.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/at-home-drug-of-abuse-testing-market?sp

At-Home Drug of Abuse (DOA) Testing Market: Major Players

Abbott Laboratories, OraSure Technologies, Inc., Psychemedics Corporation, NMS Labs, Premier Biotech, First Check Diagnostics, Atlas Medical, Cliawaived, Inc., and Frenovo Biotech, among others.

Segment Covered in the At-Home Drug of Abuse (DOA) Testing Market:

➥ By Product: Urine Drug Test Kits, Oral Fluid Drug Test Kits, Hair Drug Test Kits, Saliva Drug Test Kits, Others

➥ By Drug Type: Marijuana (THC), Amphetamines, Opiates, Benzodiazepines, Methamphetamines, Others

➥ By End User: Hospitals, Diagnostic Centers, Clinical Laboratories, Homecare Settings

Research Process:

Both primary and secondary data sources have been used in the At-Home Drug of Abuse (DOA) Testing Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the At-Home Drug of Abuse (DOA) Testing Market Research Industry:

➠ Who leads the At-Home Drug of Abuse (DOA) Testing industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do At-Home Drug of Abuse (DOA) Testing market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting At-Home Drug of Abuse (DOA) Testing market growth?
➠ What are the dominant sales and distribution strategies in the At-Home Drug of Abuse (DOA) Testing industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=at-home-drug-of-abuse-testing-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States At-Home Drug of Abuse (DOA) Testing Market valuation $5.09 billion by 2033 - Exclusive Report by DatamIntelligence here

News-ID: 4220778 • Views:

More Releases from DataM intelligence 4 Market Research LLP

France Probiotic Cosmetics Market valuation $136.26 million by 2028 - Exclusive Report by DatamIntelligence
France Probiotic Cosmetics Market valuation $136.26 million by 2028 - Exclusive …
"The France probiotic cosmetics market recorded a value of US$ 108.26 million in 2024 and is expected to reach a value of US$ 136.26 million in 2028, growing at a CAGR of 6.04% during the forecast period (2025-2028)." As per DataM intelligence research report Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/france-probiotic-cosmetics-market?sp France: Recent Industry Developments ✅ In September 2025, L'Oréal launched a new probiotic skincare line in France,
Germany Craft Spirits Market valuation $10,070.59 million by 2032 - Exclusive Report by DatamIntelligence
Germany Craft Spirits Market valuation $10,070.59 million by 2032 - Exclusive Re …
"Germany Craft Spirits Market reached US$ 1,767.20 million in 2024 and is expected to reach US$ 10,070.59 million by 2032, growing with a CAGR of 24.30% during the forecast period 2025-2032." As per DataM intelligence research report Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/germany-craft-spirits-market?sp Germany: Recent Industry Developments ✅ In September 2025, Mast-Jägermeister SE launched a new line of craft herbal spirits with unique botanical blends, targeting premium
Korea Breast Augmentation Market valuation $122.80 million by 2033 - Exclusive Report by DatamIntelligence
Korea Breast Augmentation Market valuation $122.80 million by 2033 - Exclusive R …
"The Korea Breast Augmentation Market reached US$ 70.58 million in 2024 and is expected to reach US$ 122.80 million by 2033, growing at a CAGR of 8.1 % during the forecast period 2025-2033." As per DataM intelligence research report Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/korea-breast-augmentation-market?sp South Korea: Recent Industry Developments ✅ In September 2025, Motiva Korea launched next-generation breast implants with advanced silicone gel and improved safety
United States Hematology Market valuation $13.74 billion by 2033 - Exclusive Report by DatamIntelligence
United States Hematology Market valuation $13.74 billion by 2033 - Exclusive Rep …
"The global hematology market is projected to grow from US$ 7.41 billion in 2024 to US$ 13.74 billion by 2033, registering a CAGR of 7.1% during the forecast period 2024-2033" As per DataM intelligence research report Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/hematology-market?sp United States: Recent Industry Developments ✅ In September 2025, AbbVie launched a next-generation therapy for chronic lymphocytic leukemia with improved efficacy and reduced side effects,

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase